Recent Press Releases

Affinivax Secures Additional Funding to Advance its Novel Pneumococcal Vaccine towards Clinical Trials

Company achieves key milestones and additional $2.5 million from the Gates Foundation Cambridge, Mass., Feb. 5, 2016 – Affinivax Inc., a biotechnology company dedicated to developing novel...

Mymetics Announces Discontinuation of the RSV Collaborative Project

January 28, 2016: 10:00 PM ET Mymetics Corporation (OTCQB:MYMX), a pioneer and leader in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases,...

Most vaccine-related posts on Pinterest are anti-vaccine, reveals research

Amsterdam, February 1, 2016 - 75% of the vaccine-related posts on Pinterest are negative towards vaccination, according to research published in Vaccine. The authors of the study, from Virginia...

GSK announces US regulatory submission seeking expanded indication for FluLaval® Quadrivalent (Influenza Vaccine) for infants 6 mos+

GSK today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration for FLULAVAL® QUADRIVALENT (Influenza Vaccine). This vaccine is...

Chickenpox, shingles vaccine may cause corneal inflammation in some patients

COLUMBIA, Mo. (Jan. 20, 2016) -- In use for more than 20 years, the varicella zoster virus vaccine for chickenpox and shingles is considered an essential medicine by the World Health Organization...

VALNEVA Announces Successful Establishment of New Global Marketing and Distribution Network

IXIARO® marketing and distribution handover largely completed - excellent IXIARO® sales performance in 2015 and successful transition Valneva sales and marketing organizations established in...

Stellar Biotechnologies and Neovacs Propose to Form Joint Venture to Manufacture Conjugated Therapeutic Vaccines With Stellar KLH(TM)

PORT HUENEME, CA and PARIS, FRANCE and BOSTON, MA--(Marketwired - Jan 20, 2016) - Stellar Biotechnologies, Inc. ("Stellar") (NASDAQ: SBOT) (TSX VENTURE: KLH) and Neovacs S.A....

Novavax Prices $300 Million of Convertible Senior Notes Due 2023

GAITHERSBURG, Md., Jan. 25, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant...

Takeda Announces New Drug Application Approval in Japan for a Haemophilus influenzae type b conjugate vaccine, "VAXEM Hib"

Osaka, Japan, January 22, 2016 - Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the Japanese Ministry of Health, Labour and Welfare has approved the New Drug Application...

GlaxoSmithKline statement on Zika

GSK has been closely monitoring the outbreak of Zika in Brazil since it began in the fall. Like dengue, Zika is a Flavivirus but we think it is very unlikely that our dengue candidate vaccine or...

GeneOne Life Science and Inovio Pharmaceuticals to Collaborate on Zika Virus Vaccine Development

There is no vaccine or treatment for this fast-spreading virus threatening Latin America with new cases in the U.S. SEOUL, South Korea, Jan. 22, 2016 (GLOBE NEWSWIRE) -- GeneOne Life Science...

Mucosis Secures €3.7M from Wellcome Trust to Fund Clinical Trials of its Respiratory Syncytial Virus Vaccine in Partnership with Imperial College London

Mucosis B.V., a clinical stage biotechnology company using a proprietary technology platform to develop next-generation and needle-free human vaccines for infectious diseases, today announced that it...

Inovio Pharma (INO) Awarded Grant to Advance Needle-Free Vaccine Delivery Device

PLYMOUTH MEETING, Pa., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today it has been selected to receive a $500,000 grant from the U.S. Army's Small Business...

Ebola vaccine purchasing commitment from Gavi to prepare for future outbreaks

Davos, 20 January 2016 – Gavi, the Vaccine Alliance and Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (known as MSD outside the U.S. and Canada) have signed an agreement...

FDA approves expanded use of GSK Hib vaccine from booster dose to full series

15 January 2016 Issued: Philadelphia GSK [LSE/NYSE: GSK] announced today that the U.S. Food and Drug Administration approved an expanded age indication for HIBERIX® [Haemophilus b Conjugate...

SANOFI PASTEUR PROVIDES KEY SUPPORT TO THE HUMAN VACCINES PROJECT

January 14, 2016 - The research program is designed to accelerate the development of vaccines by decoding the human immune system - Lyon, France - January 14, 2016 - Sanofi Pasteur, the vaccines...

River blindness vaccine edges closer

Researchers have taken a major step towards developing a vaccine against river blindness, also known as onchocerciasis, which affects an estimated 17 million people throughout the world. More than 90...

Cholera vaccine supply set to double, easing global shortage

Globally, OCV production is low, with demands currently exceeding supply. Sudan and Haiti last year made requests to WHO for supplies of vaccines to conduct pre-emptive vaccination campaigns that...

Moderna Therapeutics, Through Valera, its Infectious Disease Venture, Announces Initial Grant of up to $20 Million to Advance mRNA-Based Antibody Combination to Help Prevent HIV Infection

January 12, 2016 07:30 AM Eastern Standard Time CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna Therapeutics, a pioneer in the development of messenger RNA (mRNA) Therapeutics™, today announced a...

Aimmune Therapeutics Enrolls First Patient in Phase 3 PALISADE Trial of AR101 for the Treatment of Peanut Allergy

BRISBANE, CA, USA I January 11, 2016 I Aimmune Therapeutics, Inc. (Nasdaq:AIMT), a biopharmaceutical company developing desensitization treatments for food allergies, announced today that it has...